Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial
Ruanne V. Barnabas(Harvard University), Susan Morrison, Elizabeth A. Bukusi(University of California, San Francisco), R. Scott McClelland(University of Nairobi), Hannah Leingang(University of Washington), Nelly Mugo(University of Washington), Maricianah Onono(Kenya Medical Research Institute), Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kate B. Heller(University of Washington), Connie Celum(University of Washington), Rachel L. Winer(University of Washington), Elizabeth R. Brown(Fred Hutch Cancer Center), Stephen Cherne, Betty Njoroge(Kenya Medical Research Institute), Denise A. Galloway(Fred Hutch Cancer Center), Elena Rechkina(University of Washington)
Cited by 52
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus Infection
|New England Journal of Medicine|1992|952
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891